Compare Nuwellis Inc (NUWE) vs IAC/Interactivecorp (PPLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs IAC/Interactivecorp — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while IAC/Interactivecorp trades at $40.88 (market cap $3.05B). The key difference: IAC/Interactivecorp is far larger — about 1386.4× Nuwellis Inc's market cap, and IAC/Interactivecorp is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and IAC/Interactivecorp for 79 Days on average.
| NUWE | PPLI | |
|---|---|---|
Market Cap | $2.20M | $3.05B |
Volume | 121,544 | 931,019 |
Sector | Health | Media |
52-Week High | $146.65 | $47.62 |
52-Week Low | $0.68 | $31.52 |
Typical Hold Time | 26 Days | 79 Days |
Enterprise Value | -$1.52M | $3.53B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
PPLI trades at $40.85, up 0.64% on the day, with a bullish technical signal from moving averages. The stock has shown volatile earnings, missing estimates in Q4 2025 and Q1 2026 but beating in Q2 2026. Recent news highlights potential M&A activity, with MGM Resorts considering a bid for the company after PPLI withdrew its own offer to buy MGM, driving significant price movement. Valuation ratios appear attractive with a P/E of 6.92 and P/B of 0.6, though profitability metrics are mixed amid revenue declines from $5.2B in 2022 to $2.4B in 2025.
The outlook is cautiously optimistic due to strong analyst support (71.43% buy ratings) and speculative M&A upside, but risks include inconsistent earnings, high debt levels, and competitive pressures in the media sector. Net cash flow turned deeply negative in 2025 at -$820.42M, underscoring financial volatility. Investors should weigh the low valuation against execution challenges and industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About IAC/Interactivecorp
IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →
